The 2025 revision of JPOS/JASCC clinical guidelines for delirium in adult patients with cancer: a summary of recommendations
- 21 September 2026
- journal article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
Abstract
Background: The Japan Psycho-Oncology Society and the Japanese Association of Supportive Care in Cancer revised the clinical practice guidelines for delirium in adult patients with cancer in 2025. In this article, we describe the guideline revision and summarize the updated recommendations. Methods: These guidelines were developed in accordance with the Minds Manual for Clinical Practice Guideline Development 2020. The multidisciplinary guideline development group formulated four new clinical questions (CQs) addressing delirium prevention (ramelteon and orexin receptor antagonists) and management (combination therapies of antipsychotics with either benzodiazepines or antihistamines). In addition, systematic reviews of 11 existing CQs were updated. Results: Multicomponent interventions were strongly recommended for delirium prevention, based on moderate-certainty evidence. Bright light therapy, antipsychotics, ramelteon, and orexin receptor antagonists were not recommended for prevention. For delirium management, antipsychotics, trazodone, the combination of antipsychotics and benzodiazepines, and opioid switching were suggested, whereas hydroxyzine, benzodiazepines alone, and the combination of antipsychotics and antihistamines were not recommended. All recommendations for delirium management were weak, with low- to very-low-certainty evidence. Background questions addressed delirium assessment tools, precipitating factors, non-pharmacological interventions, and interventions for terminally ill patients. Conclusions: These revised clinical practice guidelines can serve as a practical framework for optimizing prevention, assessment, and management of delirium in adult patients with cancer in Japan.Keywords
Funding Information
- Japan Psycho-Oncology Society
This publication has 119 references indexed in Scilit:
- An association between cancer type and delirium incidence in Japanese elderly patients: A retrospective longitudinal studyCancer Medicine, 2022
- Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unitCochrane Database of Systematic Reviews, 2020
- Drug therapy for delirium in terminally ill adultsCochrane Database of Systematic Reviews, 2020
- Effect of the Tailored, Family-Involved Hospital Elder Life Program on Postoperative Delirium and Function in Older AdultsJAMA Internal Medicine, 2020
- Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of DeliriumJAMA Psychiatry, 2019
- Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative CareJAMA, 2017
- Effect of a Modified Hospital Elder Life Program on Delirium and Length of Hospital Stay in Patients Undergoing Abdominal SurgeryJAMA Surgery, 2017
- Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative CareJAMA Internal Medicine, 2017
- Delirium in patients undergoing hematopoietic stem cell transplantationCancer, 2002
- Occurrence, Causes, and Outcome of Delirium in Patients With Advanced CancerArchives of internal medicine (1960), 2000